Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 15;7(3):870-81.
eCollection 2014.

Interleukin 7 signaling prevents apoptosis by regulating bcl-2 and bax via the p53 pathway in human non-small cell lung cancer cells

Affiliations

Interleukin 7 signaling prevents apoptosis by regulating bcl-2 and bax via the p53 pathway in human non-small cell lung cancer cells

Zi-Hui Liu et al. Int J Clin Exp Pathol. .

Abstract

Interleukin 7/Interleukin 7 receptor (IL-7/IL-7R) signaling induces the upregulation of cyclin D1 to promote cell proliferation in lung cancer, but its role in preventing the apoptosis of non-small cell lung cancer (NSCLC) cell lines remains unknown. To study the role of IL-7 in lung cancer cell apoptosis, normal HBE cells as well as A549 and H1299 NSCLC cells were examined using flow cytometry. The results showed that the activation of IL-7R by its specific ligand, exogenous interleukin-7, was associated with a significant decline in apoptotic cells. Western blot and real-time PCR assays indicated that the activation of IL-7/IL-7R significantly upregulated anti-apoptotic bcl-2 and downregulated pro-apoptotic bax and p53 at both protein and mRNA levels. The knockdown of IL-7R through small interfering RNAs significantly attenuated these effects of exogenous IL-7. However, there was no significant anti-apoptotic effect in H1299 (p53-) cells. Furthermore, the inhibition of p53 significantly abolished the effects of IL-7/IL-7R on lung cancer cell apoptosis. These results strongly suggest that IL-7/IL-7R prevents apoptosis by upregulating the expression of bcl-2 and by downregulating the expression of bax, potentially via the p53 pathway in A549 and HBE cells.

Keywords: Interleukin 7; NSCLC; apoptosis; interleukin 7 receptor; p53.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expression of IL-7R in NSCLC cell lines. A, B: The protein and mRNA expression level of IL-7R was analyzed by western blotting and real-time PCR in HBE, A549, and H1299 cell lines. C, D: Western blot analysis and real-time PCR analysis of IL-7R depletion efficiency in HBE, A549, and H1299 cells at the protein and transcriptional level.
Figure 2
Figure 2
Effect of IL-7/IL-7R on apoptosis in A549 and HBE cells. A, B: A549 and HBE cells were treated with IL-7 (20 ng/ml) for 24 h after transfection with IL-7R siRNA (siIL-7R). C: After treatment, apoptosis was estimated using Annexin V staining. Each bar represents the mean±SD of three independent experiments. *p<0.05 or **p<0.01, compared with negative control cells.
Figure 3
Figure 3
Effect of IL-7/IL-7R on the expression of bcl-2 and bax in A549 and HBE cells. A, B: A549 and HBE cells were treated with IL-7 (20 ng/ml) for 24 h after transfection with IL-7R siRNA (siIL-7R). After treatment, the expression of bcl-2 and bax at both protein and mRNA was estimated using western blotting and real-time PCR. Each bar represents the mean±SD of three independent experiments. *p<0.05 or **p<0.01, compared with negative control cells.
Figure 4
Figure 4
Effect of IL-7/IL-7R on the expression of p53 in A549 and HBE cells. A, B: A549 and HBE cells were treated with IL-7 (20 ng/ml) for 24 h after transfection with IL-7R siRNA (siIL-7R). After treatment, the expression of p53 at both protein and mRNA was estimated using western blotting and real-time PCR. Each bar represents the mean±SD of three independent experiments. *p<0.05 or **p<0.01, compared with negative control cells.
Figure 5
Figure 5
Effect of IL-7/IL-7R on apoptosis in A549 and HBE cells after inhibiting p53 activation. A: A549 and HBE cells were divided into five groups as described in Methods section. B: Apoptosis was estimated using the Annexin V staining. Each bar represents the percentage of Annexin positive cells of three independent experiments. *p<0.05, or **p<0.01, compared with negative control cells.
Figure 6
Figure 6
Effect of IL-7/IL-7R on the expression of bcl-2 and bax in A549 and HBE cells after inhibiting p53 activation. A: A549 and HBE cells were divided into five groups. The expression of IL-7R, p53, bcl-2 and bax protein level was estimated using western blotting. B: Densitometry analysis of western blot experiments. Data were normalized against GAPDH and each bar represents the mean±SD of three independent experiments. *p<0.05 or **p<0.01, compared with negative control cells.
Figure 7
Figure 7
Effect of IL-7/IL-7R on apoptosis in H1299 cells. A: H1299 cells were treated with IL-7 (20 ng/ml) for 24 h after transfection with IL-7R siRNA (siIL-7R). After treatment, apoptosis was estimated using Annexin V staining. B: Each bar represents the percentage of Annexin-positive cells from three independent experiments. C: The expression of bcl-2 and bax protein was estimated using western blotting. D: Densitometry analysis of western blot experiments. Data were normalized against GAPDH and each bar represents the mean±SD of three independent experiments.

References

    1. Kibe R, Zhang S, Guo D, Marrero L, Tsien F, Rodriguez P, Khan S, Zieske A, Huang J, Li W, Durum SK, Iwakuma T, Cui Y. IL-7Ra deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis. Cell Death Differ. 2012;19:1139–51. - PMC - PubMed
    1. Sammicheli S, Dang VP, Ruffin N, Pham HT, Lantto R, Vivar N, Chiodi F, Rethi B. IL-7 Promotes CD95-Induced Apoptosis in B Cells via the IFN-γ/STAT1 Pathway. PLoS One. 2011;12:e28629. - PMC - PubMed
    1. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol. 2004;22:625–55. - PubMed
    1. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet. 1998;20:394–7. - PubMed
    1. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med. 1994;180:1955–60. - PMC - PubMed

Publication types

MeSH terms